The Manila Times
OPINION
NEWS
REGIONS
WORLD
BUSINESS
SPORTS
ENTERTAINMENT
LIFESTYLE
THE SUNDAY TIMES
SPECIAL FEATURES
SPECIAL SECTIONS
TMT NEWSWIRE
FAST TIMES
LEGAL ADVICE
CAMPUS PRESS
VIDEOS
EXPATS & DIPLOMATS
PHOTOS
BUSINESS FORUM
PODCASTS
RESOURCES
WEATHER
MARKET OVERVIEW
CLASSIFIEDS
EXAM RESULTS
TMT DIGITAL EDITION
TMT CSI
TMT 126TH ANNIVERSARY
QUIZZES
GAMES
TMT Newswire > GlobeNewswire
by The Manila Times
Mar 17, 2025 1:34 am

Related Articles

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress

Kaldalón hf.: Annual General Meeting - Final Agenda and Board Candidates

KOIL Energy Announces Delay in Filing of Annual Report on Form 10-K and anticipates reporting profitable growth in revenues

Ambia Solar Headquarters Move to Lindon, Utah

GivBux Details $212 Million Strategic Investment; Commits $212 Million to an Asset-Based Investment Vehicle

HII Celebrates 2024 Graduates of The Newport News Shipbuilding Apprentice School

Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk